Cargando…

An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic

OBJECTIVE: The COVID-19 pandemic presented new care delivery obstacles in the form of scheduling procedures and safe presentation to in-person visits. Contraception provision is an indispensable component of postpartum care that was not immune to these challenges. Given the barriers to care during t...

Descripción completa

Detalles Bibliográficos
Autores principales: LAGON, Elena P., MAUNEY, Logan, ONWUZURIKE, Chiamaka, SHAHAWY, Sarrah, SCHAEFER, Kimberly, STAROSTA, Anabel, YE, Sonya, BARTZ, Deborah, SCHANTZ-DUNN, Julianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077763/
https://www.ncbi.nlm.nih.gov/pubmed/37031561
http://dx.doi.org/10.1016/j.srhc.2023.100844
_version_ 1785020374452273152
author LAGON, Elena P.
MAUNEY, Logan
ONWUZURIKE, Chiamaka
SHAHAWY, Sarrah
SCHAEFER, Kimberly
STAROSTA, Anabel
YE, Sonya
BARTZ, Deborah
SCHANTZ-DUNN, Julianna
author_facet LAGON, Elena P.
MAUNEY, Logan
ONWUZURIKE, Chiamaka
SHAHAWY, Sarrah
SCHAEFER, Kimberly
STAROSTA, Anabel
YE, Sonya
BARTZ, Deborah
SCHANTZ-DUNN, Julianna
author_sort LAGON, Elena P.
collection PubMed
description OBJECTIVE: The COVID-19 pandemic presented new care delivery obstacles in the form of scheduling procedures and safe presentation to in-person visits. Contraception provision is an indispensable component of postpartum care that was not immune to these challenges. Given the barriers to care during the initial months of the pandemic, we sought to examine how postpartum contraception, sterilization, and visit attendance were affected during this period. Study Design. We performed a retrospective chart review to examine contraception initiation, sterilization, and postpartum virtual and in-person visit attendance rates during the first six months (March 15 to September 7, 2020) of the COVID-19 pandemic compared to the rates in the same period in the year prior at a single tertiary academic care center. We abstracted data from the first prenatal visit through twelve weeks postpartum. RESULTS: With the initiation of virtual appointments, postpartum visit attendance significantly increased (94.6 % vs 88.4 %, p < 0.001) during the pandemic with no difference in overall contraception uptake (51 % vs 54.1 %, p = 0.2) or sterilization (11.0 % vs 11.5 %, p = 0.88). During the pandemic, contraception prescribed differed significantly with a trend towards patient-administered methods including pills, patches, and rings (21 % vs 16 %, p = 0.02). In both periods, there was a significantly younger mean age (p < 0.001), higher proportion of non-White and non-Asian race (p < 0.001), public insurance (p = 0.003, 0.004), and an established contraceptive plan prenatally (p < 0.001) in the group that received contraception. CONCLUSION: As virtual postpartum visits were instituted, contraception initiation and sterilization were maintained at pre-pandemic rates and visit attendance rose despite the obstacles to care presented by the COVID-19 pandemic. Provision of virtual postpartum visits may be a driver to maintain contraception and sterilization rates at a time, such as early in the COVID-19 pandemic, when patient care is at risk to be disrupted by social distancing, isolation, and avoidance of medical campuses.
format Online
Article
Text
id pubmed-10077763
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-100777632023-04-06 An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic LAGON, Elena P. MAUNEY, Logan ONWUZURIKE, Chiamaka SHAHAWY, Sarrah SCHAEFER, Kimberly STAROSTA, Anabel YE, Sonya BARTZ, Deborah SCHANTZ-DUNN, Julianna Sex Reprod Healthc Article OBJECTIVE: The COVID-19 pandemic presented new care delivery obstacles in the form of scheduling procedures and safe presentation to in-person visits. Contraception provision is an indispensable component of postpartum care that was not immune to these challenges. Given the barriers to care during the initial months of the pandemic, we sought to examine how postpartum contraception, sterilization, and visit attendance were affected during this period. Study Design. We performed a retrospective chart review to examine contraception initiation, sterilization, and postpartum virtual and in-person visit attendance rates during the first six months (March 15 to September 7, 2020) of the COVID-19 pandemic compared to the rates in the same period in the year prior at a single tertiary academic care center. We abstracted data from the first prenatal visit through twelve weeks postpartum. RESULTS: With the initiation of virtual appointments, postpartum visit attendance significantly increased (94.6 % vs 88.4 %, p < 0.001) during the pandemic with no difference in overall contraception uptake (51 % vs 54.1 %, p = 0.2) or sterilization (11.0 % vs 11.5 %, p = 0.88). During the pandemic, contraception prescribed differed significantly with a trend towards patient-administered methods including pills, patches, and rings (21 % vs 16 %, p = 0.02). In both periods, there was a significantly younger mean age (p < 0.001), higher proportion of non-White and non-Asian race (p < 0.001), public insurance (p = 0.003, 0.004), and an established contraceptive plan prenatally (p < 0.001) in the group that received contraception. CONCLUSION: As virtual postpartum visits were instituted, contraception initiation and sterilization were maintained at pre-pandemic rates and visit attendance rose despite the obstacles to care presented by the COVID-19 pandemic. Provision of virtual postpartum visits may be a driver to maintain contraception and sterilization rates at a time, such as early in the COVID-19 pandemic, when patient care is at risk to be disrupted by social distancing, isolation, and avoidance of medical campuses. Elsevier B.V. 2023-06 2023-04-06 /pmc/articles/PMC10077763/ /pubmed/37031561 http://dx.doi.org/10.1016/j.srhc.2023.100844 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
LAGON, Elena P.
MAUNEY, Logan
ONWUZURIKE, Chiamaka
SHAHAWY, Sarrah
SCHAEFER, Kimberly
STAROSTA, Anabel
YE, Sonya
BARTZ, Deborah
SCHANTZ-DUNN, Julianna
An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic
title An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic
title_full An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic
title_fullStr An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic
title_full_unstemmed An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic
title_short An assessment of postpartum contraception rates with evolving care during the COVID-19 pandemic
title_sort assessment of postpartum contraception rates with evolving care during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077763/
https://www.ncbi.nlm.nih.gov/pubmed/37031561
http://dx.doi.org/10.1016/j.srhc.2023.100844
work_keys_str_mv AT lagonelenap anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT mauneylogan anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT onwuzurikechiamaka anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT shahawysarrah anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT schaeferkimberly anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT starostaanabel anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT yesonya anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT bartzdeborah anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT schantzdunnjulianna anassessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT lagonelenap assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT mauneylogan assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT onwuzurikechiamaka assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT shahawysarrah assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT schaeferkimberly assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT starostaanabel assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT yesonya assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT bartzdeborah assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic
AT schantzdunnjulianna assessmentofpostpartumcontraceptionrateswithevolvingcareduringthecovid19pandemic